Webinar | August 20, 2023

Validation Of mRNA Concentration Determination Using Variable Pathlength Spectroscopy

Source: Aldevron

Developing mRNA-based therapeutics requires comprehensive analytical testing in order to meet regulatory requirements. However, developers face the challenge of balancing pre-clinical and clinical testing with the need to remain competitive in the market. Optimizing processes to ensure analytical testing results are fast and reliable is critical as you bring your product to market.

Travis Alvine, Ph.D., Senior Manager for Analytical Method Validation, Aldevron, and Joe Ferraiolo, Director of Bioanalytical Applications, Repligen, discuss considerations for variable pathlength technology as well as the importance of ensuring regulatory compliance and prioritizing quality and patient safety.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene